Cardiac-Specific expression of the tetracycline transactivator confers increased heart function and survival following ischemia reperfusion injury

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Elsherif, Laila ^a   Wang, Xuerong ^a   Grachoff, Milana ^a   Wolska, Beata M ^a   Geenen, David L ^a   O'Bryan, John P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CREATINE KINASE; MYOSIN HEAVY CHAIN ALPHA; TETRACYCLINE TRANSACTIVATOR TRANSCRIPTION FACTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; MYOSIN HEAVY CHAIN; PHOSPHATIDYLINOSITOL 3 KINASE; TETRACYCLINE; VENTRICULAR MYOSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; HEART DEVELOPMENT; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; REPERFUSION INJURY; SURVIVAL; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; HEART; HEART INFARCTION; HEART MUSCLE; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PROMOTER REGION; RAT; TRANSGENIC MOUSE;

ANIMALIA; MUS; MUS MUSCULUS; RATTUS;

ANIMALS; CHROMONES; CREATINE KINASE; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHOLINES; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN SIZE; PHOSPHATIDYLINOSITOL 3-KINASES; PROMOTER REGIONS, GENETIC; RATS; REPERFUSION INJURY; TETRACYCLINE; TRANS-ACTIVATORS; VENTRICULAR MYOSINS;

EID: 84855857750     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030129     Document Type: Article

References (21)

1. Gossen M, Bujard H, (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.
2. Passman RS, Fishman GI, (1994) Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest 94: 2421-2425.
3. Yu Z, Redfern CS, Fishman GI, (1996) Conditional transgene expression in the heart. Circ Res 79: 691-697.
4. Barandon L, Dufourcq P, Costet P, Moreau C, Allieres C, et al. (2005) Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ Res 96: 1299-1306.
5. Loyer X, Gomez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, et al. (2008) Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation 117: 3187-3198.
6. Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, et al. (2007) Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J 21: 3133-3141.
7. Tian R, Miao W, Spindler M, Javadpour MM, McKinney R, et al. (1999) Long-term expression of protein kinase C in adult mouse hearts improves postischemic recovery. Proc Natl Acad Sci U S A 96: 13536-13541.
8. McCloskey DT, Turnbull L, Swigart PM, Zambon AC, Turcato S, et al. (2005) Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression. Physiol Genomics 22: 118-126.
9. Turnbull L, Zhou HZ, Swigart PM, Turcato S, Karliner JS, et al. (2006) Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator. Am J Physiol Heart Circ Physiol 290: H1103-1109.
10. O'Bryan JP, (2010) Intersecting pathways in cell biology. Sci Signal 3: re10.
11. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J Jr, (2002) Impact of anesthesia on cardiac function during echocardiography in mice. Am J Physiol Heart Circ Physiol 282: H2134-2140.
12. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, et al. (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115: 2128-2138.
13. Reichelt ME, Willems L, Hack BA, Peart JN, Headrick JP, (2009) Cardiac and coronary function in the Langendorff-perfused mouse heart model. Exp Physiol 94: 54-70.
14. Sutherland FJ, Shattock MJ, Baker KE, Hearse DJ, (2003) Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol 30: 867-878.
15. DeBoer LW, Strauss HW, Kloner RA, Rude RE, Davis RF, et al. (1980) Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. Proc Natl Acad Sci U S A 77: 6119-6123.
16. Redel A, Jazbutyte V, Smul TM, Lange M, Eckle T, et al. (2008) Impact of ischemia and reperfusion times on myocardial infarct size in mice in vivo. Exp Biol Med (Maywood) 233: 84-93.
17. Wang QD, Swardh A, Sjoquist PO, (2001) Relationship between ischaemic time and ischaemia/reperfusion injury in isolated Langendorff-perfused mouse hearts. Acta Physiol Scand 171: 123-128.
18. Yellon DM, Downey JM, (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83: 1113-1151.
19. Mocanu MM, Yellon DM, (2007) PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? Br J Pharmacol 150: 833-838.
20. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, et al. (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19: 2537-2548.
21. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, et al. (2003) Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 92: 609-616.